berbamine has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, W; He, H; Liu, Y; Niu, Y; Shi, Y; Tang, Z; Wu, T; Xu, Z; Zheng, M | 1 |
| Cai, H; Chen, G; Chen, X; Hu, B; Tu, J; Yang, S; Yang, Y | 1 |
| Jin, X; Wu, Y | 1 |
3 other study(ies) available for berbamine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Anti-Tumor and Anti-Metastasis Effects of Berbamine-Loaded Lipid Nanoparticles on Pancreatic Cancer.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Caspase 3; Cell Line, Tumor; Dopamine; Humans; Liposomes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2022 |
Berbamine Exerts an Anti-oncogenic Effect on Pancreatic Cancer by Regulating Wnt and DNA Damage-related Pathways.
Topics: Animals; Apoptosis; Benzylisoquinolines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Pancreatic Neoplasms | 2023 |
Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxycytidine; Down-Regulation; Drug Interactions; Gemcitabine; Humans; Pancreatic Neoplasms; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |